GALT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 52.70%

Insider Buying (Last 12 Months): $11,205.42

Insider Selling (Last 12 Months): $0.00

Galectin Therapeutics Insider Trading History Chart

Galectin Therapeutics Share Price & Price History

^$3.29

▼ -0.09 (-2.66%)

As of 04/24/2024 01:00 AM ET

Days: 30 | 90 | 365

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

Galectin Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/22/2024	Kevin D. Freeman	Director	Buy	2,500	$2.98	$7,450.00	25,969
1/16/2024	Kary Eldred	Director	Buy	500	$1.79	$895.00	49,313
7/19/2023	Kary Eldred	Director	Buy	1,598	$1.79	$2,860.42	48,813
2/21/2023	Kary Eldred	Director	Buy	1,000	$1.59	$1,590.00	47,215
2/16/2023	Joel Lewis	CEO	Buy	1,000	$1.52	$1,520.00	1,000
1/25/2023	Kary Eldred	Director	Buy	1,300	$1.11	$1,443.00	46,215
11/17/2022	Jack W Callicutt	CFO	Buy	4,000	$1.32	$5,280.00	7,614
10/28/2022	Kevin D. Freeman	Director	Buy	10,000	$1.41	$14,100.00	75,000
7/28/2022	Richard A. Zordani, Jr.	Director	Buy	5,000	$2.50	$12,500.00	29,583
5/19/2022	Kevin D. Freeman	Director	Buy	5,000	$1.33	$6,650.00	65,000
4/18/2022	Kevin D. Freeman	Director	Buy	5,000	$1.71	$8,550.00	60,000
4/4/2022	Richard A. Zordani, Jr.	Director	Buy	5,000	$1.60	$8,000.00	24,583
2/2/2022	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.10	$21,000.00
1/21/2022	Elissa J. Schwartz	Director	Buy	1,000	$2.00	$2,000.00
1/19/2022	Kevin D. Freeman	Director	Buy	5,000	$1.96	$9,800.00
1/14/2022	Richard A. Zordani, Jr.	Director	Buy	5,000	$2.02	$10,100.00
1/11/2022	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.10	$21,000.00
12/6/2021	Kevin D. Freeman	Director	Buy	5,000	$2.34	$11,700.00
12/2/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.37	$23,700.00
11/1/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.19	$31,900.00
10/29/2021	Kevin D. Freeman	Director	Buy	2,000	$3.17	$6,340.00
10/21/2021	Kevin D. Freeman	Director	Buy	2,000	$3.19	$6,380.00
10/19/2021	Kevin D. Freeman	Director	Buy	3,000	$3.37	$10,110.00
10/15/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.37	$33,700.00
10/4/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.62	$36,200.00
9/23/2021	Kevin D. Freeman	Director	Buy	3,000	$3.88	$11,640.00
9/1/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.91	$39,100.00
8/2/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.25	$32,500.00
7/9/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.54	$35,400.00
5/3/2021	Fund L.P. 10X	Major Shareholder	Sell	27,500	$3.97	$109,175.00

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

SEC Filings (Institutional Ownership Changes) for Galectin Therapeutics (NASDAQ:GALT)

11.68% of Galectin Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Galectin Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/19/2024	Retirement Guys Formula LLC	33,732	$81K	0.0%	+56.9%	0.054%
2/6/2024	Solutions 4 Wealth Ltd	36,085	$60K	0.2%	N/A	0.058%
2/2/2024	Atria Wealth Solutions Inc.	249,800	$0.42M	0.0%	-3.8%	0.404%
2/1/2024	Cutter & CO Brokerage Inc.	117,488	$0.20M	0.1%	-9.3%	0.190%
1/22/2024	Retirement Guys Formula LLC	21,500	$36K	0.0%	+87.0%	0.035%
1/9/2024	Beacon Capital Management LLC	23,905	$40K	0.0%	+89.6%	0.039%
11/8/2023	D.A. Davidson & CO.	37,825	$73K	0.0%	+15.2%	0.061%
10/16/2023	Traynor Capital Management Inc.	34,707	$67K	0.0%	N/A	0.056%
10/11/2023	AE Wealth Management LLC	26,841	$52K	0.0%	+72.7%	0.043%
8/3/2023	Atria Wealth Solutions Inc.	260,800	$0.38M	0.0%	-3.7%	0.439%
7/25/2023	Summit Trail Advisors LLC	20,000	$29K	0.0%	N/A	0.034%
7/13/2023	Cambridge Investment Research Advisors Inc.	134,332	$0.19M	0.0%	-5.7%	0.226%
5/12/2023	Independent Advisor Alliance	36,100	$76K	0.0%	N/A	0.061%
5/9/2023	Wealthspire Advisors LLC	183,862	$0.39M	0.0%	N/A	0.309%
5/9/2023	Wedbush Securities Inc.	15,498	$33K	0.0%	-36.7%	0.026%
4/25/2023	Geneos Wealth Management Inc.	427,400	$0.90M	0.1%	-1.7%	0.719%
2/7/2023	Commonwealth Equity Services LLC	101,522	$0.11M	0.0%	+165.6%	0.170%
2/7/2023	Benjamin F. Edwards & Company Inc.	34,412	$39K	0.0%	+78.7%	0.058%
2/3/2023	Cutter & CO Brokerage Inc.	129,488	$0.15M	0.0%	-23.6%	0.217%
1/31/2023	Geneos Wealth Management Inc.	434,800	$0.49M	0.0%	-2.3%	0.729%
11/7/2022	D.A. Davidson & CO.	32,810	$53K	0.0%	-27.6%	0.055%
7/28/2022	D.A. Davidson & CO.	45,335	$59K	0.0%	-18.0%	0.076%
7/19/2022	Commonwealth Equity Services LLC	38,220	$50K	0.0%	+42.1%	0.064%
5/4/2022	Advisor Group Holdings Inc.	1,265,820	$2.04M	0.0%	+1.5%	2.133%
5/4/2022	Commonwealth Equity Services LLC	26,902	$43K	0.0%	+59.2%	0.045%
5/3/2022	Cutter & CO Brokerage Inc.	169,578	$0.27M	0.1%	-7.6%	0.286%
2/9/2022	Geneos Wealth Management Inc.	480,767	$1M	0.0%	-2.2%	0.810%
2/7/2022	Benjamin F. Edwards & Company Inc.	29,615	$61K	0.0%	+25.5%	0.050%
2/7/2022	Ameritas Advisory Services LLC	44,232	$92K	0.0%	N/A	0.075%
2/3/2022	Cambridge Investment Research Advisors Inc.	153,027	$0.32M	0.0%	-7.0%	0.258%
2/3/2022	Advisor Group Holdings Inc.	1,247,401	$2.58M	0.0%	-2.1%	2.102%
11/16/2021	Squarepoint Ops LLC	39,191	$0.15M	0.0%	-30.2%	0.066%
11/15/2021	Capstone Investment Advisors LLC	42,260	$0.16M	0.0%	N/A	0.071%
11/12/2021	Ameritas Investment Company LLC	44,232	$0.17M	0.0%	+12.7%	0.075%
11/12/2021	Centaurus Financial Inc.	22,614	$88K	0.0%	+44.8%	0.038%
11/12/2021	Geode Capital Management LLC	540,866	$2.10M	0.0%	+32.2%	0.912%
11/10/2021	Buckingham Strategic Wealth LLC	10,734	$42K	0.0%	N/A	0.018%
11/9/2021	BlackRock Inc.	787,582	$3.06M	0.0%	-0.8%	1.328%
11/8/2021	Keybank National Association OH	100,000	$0.39M	0.0%	N/A	0.169%
11/4/2021	QCI Asset Management Inc. NY	55,000	$0.21M	0.0%	+120.0%	0.093%
11/2/2021	Raymond James & Associates	13,096	$51K	0.0%	N/A	0.022%
11/2/2021	Benjamin F. Edwards & Company Inc.	23,600	$92K	0.0%	-32.0%	0.040%
11/2/2021	Cambridge Investment Research Advisors Inc.	164,498	$0.64M	0.0%	-2.3%	0.277%
10/29/2021	Commonwealth Equity Services LLC	11,902	$46K	0.0%	N/A	0.020%
10/8/2021	Wedbush Securities Inc.	30,998	$0.12M	0.0%	+72.2%	0.052%
9/3/2021	Parametric Portfolio Associates LLC	56,047	$0.18M	0.0%	+62.9%	0.096%
8/25/2021	Marshall Wace LLP	47,509	$0.15M	0.0%	N/A	0.082%
8/17/2021	Millennium Management LLC	568,690	$1.82M	0.0%	N/A	0.979%
8/17/2021	Boothbay Fund Management LLC	10,965	$35K	0.0%	N/A	0.019%
8/16/2021	Squarepoint Ops LLC	56,128	$0.18M	0.0%	N/A	0.097%
8/16/2021	Ameritas Investment Company LLC	39,232	$0.13M	0.0%	N/A	0.068%
8/16/2021	LMR Partners LLP	19,285	$62K	0.0%	N/A	0.033%
8/16/2021	Charles Schwab Investment Management Inc.	17,413	$56K	0.0%	-77.5%	0.030%
8/16/2021	State Street Corp	158,759	$0.51M	0.0%	-74.2%	0.273%
8/16/2021	Tibra Equities Europe Ltd	98,700	$0.32M	0.1%	N/A	0.170%
8/16/2021	Marshall Wace LLP	47,509	$0.15M	0.0%	N/A	0.082%
8/13/2021	Renaissance Technologies LLC	370,199	$1.19M	0.0%	+20.6%	0.637%
8/13/2021	Northern Trust Corp	96,270	$0.31M	0.0%	-77.1%	0.166%
8/13/2021	LPL Financial LLC	52,034	$0.17M	0.0%	+219.5%	0.090%
8/13/2021	Geode Capital Management LLC	409,013	$1.31M	0.0%	-36.7%	0.704%
8/13/2021	Vanguard Group Inc.	1,953,419	$6.25M	0.0%	+1.1%	3.362%
8/12/2021	XTX Topco Ltd	12,419	$40K	0.0%	N/A	0.021%
8/12/2021	Ergoteles LLC	139,181	$0.45M	0.0%	N/A	0.240%
8/11/2021	Bank of New York Mellon Corp	23,080	$74K	0.0%	-76.9%	0.040%
8/11/2021	BlackRock Inc.	793,934	$2.54M	0.0%	-69.7%	1.367%
8/11/2021	Susquehanna Fundamental Investments LLC	15,600	$50K	0.0%	N/A	0.027%
8/10/2021	Cambridge Investment Research Advisors Inc.	168,316	$0.54M	0.0%	N/A	0.290%
8/10/2021	Rockefeller Capital Management L.P.	10,386	$33K	0.0%	+419.3%	0.018%
8/2/2021	Advisor Group Holdings Inc.	1,273,157	$4.07M	0.0%	+4.2%	2.192%
6/17/2021	Geneos Wealth Management Inc.	511,606	$2.26M	0.1%	+5.4%	0.881%
5/19/2021	Virtu Financial LLC	14,683	$32K	0.0%	N/A	0.026%
5/18/2021	D. E. Shaw & Co. Inc.	45,775	$99K	0.0%	-10.8%	0.080%
5/17/2021	Vivaldi Capital Management LLC	10,668	$45K	0.0%	-30.9%	0.019%
5/17/2021	Nuveen Asset Management LLC	177,035	$0.38M	0.0%	-4.2%	0.310%
5/14/2021	Occudo Quantitative Strategies LP	18,967	$41K	0.0%	N/A	0.033%
5/14/2021	Dimensional Fund Advisors LP	11,977	$26K	0.0%	N/A	0.021%
5/13/2021	Barclays PLC	31,094	$68K	0.0%	+159.0%	0.054%
5/13/2021	Renaissance Technologies LLC	307,000	$0.67M	0.0%	+1,864.5%	0.537%
5/13/2021	Neuberger Berman Group LLC	13,614	$30K	0.0%	-25.2%	0.024%
5/13/2021	Bank of New York Mellon Corp	99,901	$0.22M	0.0%	-7.0%	0.175%
5/13/2021	Bank of Montreal Can	21,329	$53K	0.0%	+272.7%	0.037%
5/12/2021	Northern Trust Corp	421,103	$0.91M	0.0%	-7.0%	0.737%
5/12/2021	Geode Capital Management LLC	645,867	$1.40M	0.0%	+0.6%	1.130%
5/12/2021	JPMorgan Chase & Co.	100,555	$0.22M	0.0%	-3.0%	0.176%
5/7/2021	BlackRock Inc.	2,620,626	$5.69M	0.0%	+0.9%	4.585%
5/7/2021	D.A. Davidson & CO.	65,310	$0.14M	0.0%	-91.5%	0.114%
4/26/2021	Wedbush Securities Inc.	17,998	$39K	0.0%	-12.2%	0.031%
3/2/2021	FormulaFolio Investments LLC	12,710	$28K	0.0%	N/A	0.022%
2/19/2021	JPMorgan Chase & Co.	103,713	$0.23M	0.0%	+378.5%	0.182%
2/12/2021	Raymond James Financial Services Advisors Inc.	18,229	$41K	0.0%	N/A	0.032%
2/11/2021	Northern Trust Corp	452,957	$1.01M	0.0%	-2.8%	0.794%
2/11/2021	Barclays PLC	12,006	$27K	0.0%	-30.5%	0.021%
2/10/2021	Renaissance Technologies LLC	15,627	$35K	0.0%	N/A	0.027%
2/10/2021	D.A. Davidson & CO.	767,321	$1.72M	0.0%	-10.1%	1.344%
2/9/2021	Wells Fargo & Company MN	96,815	$0.22M	0.0%	+69.1%	0.170%
2/5/2021	BlackRock Inc.	2,598,089	$5.82M	0.0%	+3.8%	4.552%
2/4/2021	Cambridge Investment Research Advisors Inc.	179,556	$0.40M	0.0%	-6.1%	0.315%
11/13/2020	Morgan Stanley	31,579	$85K	0.0%	-51.6%	0.055%
11/12/2020	JPMorgan Chase & Co.	21,674	$72K	0.0%	-22.6%	0.038%
11/10/2020	State Street Corp	698,113	$1.86M	0.0%	+1.5%	1.223%

Data available starting January 2016

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.

Today's Range

Now: $3.29

$3.27

$3.51

50 Day Range

MA: $2.51

$1.73

$4.20

52 Week Range

Now: $3.29

$1.28

$4.27

Volume

162,147 shs

Average Volume

130,337 shs

Market Capitalization

$203.65 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Who are the company insiders with the largest holdings of Galectin Therapeutics?: Galectin Therapeutics' top insider investors include:
Kevin D Freeman (Director)
Kary Eldred (Director)
Richard A Jr Zordani (Director)
Jack W Callicutt (CFO)
Joel Lewis (CEO)
Learn More about top insider investors at Galectin Therapeutics.
Who are the major institutional investors of Galectin Therapeutics?: Galectin Therapeutics' top institutional shareholders include:
Retirement Guys Formula LLC — 0.05%
Learn More about top institutional investors of Galectin Therapeutics stock.
Which major investors are buying Galectin Therapeutics stock?: In the previous quarter, GALT stock was acquired by institutional investors including:
Retirement Guys Formula LLC
In the previous year, these company insiders have bought Galectin Therapeutics stock:
Kevin D Freeman (Director)
Kary Eldred (Director)
Richard A Jr Zordani (Director)
Jack W Callicutt (CFO)
Joel Lewis (CEO)
Learn More investors buying Galectin Therapeutics stock.